People
Seattle Genetics Appoints Taylor as Chief Commercial Officer
24 May 2019 - - US-based biotechnology company Seattle Genetics, Inc. (NASDAQ: SGEN) has appointed Robin G. Taylor, M.B.A., Ph.D., as chief commercial officer, the company said.

Taylor br...
MMS Holdings names new member of board of scientific advisors
24 May 2019 - MMS Holdings Inc, a contract research organisation (CRO), announced yesterday that it has named Dr Mike Poole, MD, FACP as the member of board of scientific advisors.Currently a venture ...
Bexion Pharmaceuticals names new director
24 May 2019 - Bexion Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, announced yesterday that it has named Bob Savage, MBA as its director.Savage brings to the Bexion Board more than ...
BioArctic appoints Dr. Per-Ola Freskgård to strengthen development of technology platform
24 May 2019 - BioArctic AB (STO:BIOAB) announced on Thursday that the company has appointed Dr. Per-Ola Freskgård to strengthen BioArctic's development of its technology platform to facilit...
BioTime Names Leavitt as General Counsel
23 May 2019 - - US-based clinical-stage biotechnology company BioTime, Inc. (NYSE American) (TASE: BTX) has appointed Chase C. Leavitt as BioTime's general counsel and corporate secretary, the co...
Locana Inc concludes USD55m Series A financing
23 May 2019 - Gene therapy company Locana Inc stated on Wednesday that it has raised USD55m from its Series A financing led by existing investors ARCH Venture Partners with participation from Temasek ...